mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.4 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |